Status:
RECRUITING
Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Cerebrovascular Accident
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Neurofeedback (NF) is a procedure for providing direct sensory feedback (in the form of visual, auditory or tactile stimulation) to a patient about their brain activity when performing a cognitive or ...
Detailed Description
A large percentage of patients surviving a cerebrovascular accident (CVA) suffer motor aftereffects, notably loss of mobility of the upper limb, linked to cortical lesions. During motor rehabilitation...
Eligibility Criteria
Inclusion
- Man, woman, over 18 years old
- Motor deficit of the upper limb type of hemiplegia, secondary to a hemorrhagic or ischemic stroke authenticated by brain imaging (MRI or CT)
- Post-stroke patients in the subacute phase, between 15 days and 6 months after the stroke
- Correct or corrected vision allowing reading at a distance of 0 to 2m
- Ability to maintain a seated position for 1 hour
- Patient affiliated to a social security scheme or beneficiary of such a scheme
- Informed patient having signed consent
Exclusion
- Minors (age \< 18 years)
- Phasic disorder limiting comprehension corresponding to a Boston Diagnostic Aphasia Examination (BDAE) score \< 4
- Attentional disorder not allowing sufficient attention to be maintained for 1 hour
- History of known stroke with motor sequelae.
- Known peripheral neurological pathology affecting the paretic upper limb.
- Other known central neurological pathology
- Factors hindering EEG acquisition (scalp pathology, abnormal cervico-cephalic movements, cranial metal implants)
- Unstabilized epilepsy
- Refusal to participate in the study
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- Pregnant, parturient, or breastfeeding patient
Key Trial Info
Start Date :
January 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06212219
Start Date
January 8 2024
End Date
December 31 2025
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de TOULOUSE
Toulouse, France, 31000